← Holders
B Group, Inc.
What B Group, Inc. reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 2043476 · Filed Nov 16, 2026
- Positions
- 19
- Reported value
- $162.1M
- Opened
- 1
- Closed
- 1
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$135.9M20 positions
- Dec 31, 2025$135.4M16 positions
- Mar 31, 2026$134.9M20 positions
- Jun 30, 2026$213M19 positions
- Sep 30, 2026$162.1M19 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
ADMAAdma Biologics, Inc. | 3.3M | ±0% | $32.7M | 20.2% |
FTHFaeth Therapeutics, Inc. | 610.2K | ±0% | $18.1M | 11.2% |
PALIPalisade Bio, Inc. | 11.4M | ±0% | $15.4M | 9.5% |
NRXPNRX Pharmaceuticals, Inc. | 4.3M | +4.5% | $12.5M | 7.7% |
ZLABZai Lab Ltd | 450.6K | ±0% | $11.9M | 7.3% |
PRAXPraxis Precision Medicines, Inc. | 33.2K | ±0% | $9.7M | 6% |
SGHTSight Sciences, Inc. | 970K | ±0% | $9.1M | 5.6% |
TSHATaysha Gene Therapies, Inc. | 1.8M | ±0% | $8.8M | 5.4% |
IOVAIovance Biotherapeutics, Inc. | 425K | −71.7% | $6.3M | 3.9% |
GPCRStructure Therapeutics Inc. | 180K | +28.6% | $5.6M | 3.5% |
SYRESpyre Therapeutics, Inc. | 62.5K | −10.7% | $5.6M | 3.4% |
CLLSCellectis S.A. | 3.3M | ±0% | $5M | 3.1% |
AURAAura Biosciences, Inc. | 764.2K | ±0% | $4.8M | 3% |
DRUGBright Minds Biosciences Inc. | 95K | +40.7% | $4.7M | 2.9% |
ORKAOruka Therapeutics, Inc. | 55K | −26.7% | $4.6M | 2.8% |
ASMBAssembly Biosciences, Inc. | 175.7K | ±0% | $4.1M | 2.5% |
RAREUltragenyx Pharmaceutical Inc. | 135K | ±0% | $2M | 1.3% |
FHTXFoghorn Therapeutics Inc. | 200K | ±0% | $714K | 0.4% |
QTTBQ32 Bio Inc. | 65K | New | $537.6K | 0.3% |